Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SYH2070 in Mixed Hyperlipidemia
NCT07695597Phase 2Recruiting
- Sponsor
- CSPC Zhongnuo Pharmaceutical
- Start
- Jul 2026
- Primary completion
- Apr 2027
- Countries
- 1
01
Overview
A Phase 2 trial of SYH2070 in mixed hyperlipidemia, sponsored by CSPC Zhongnuo Pharmaceutical. Started Jul 2026; status: recruiting.
02
Drugs
SYH2070
03
Conditions
mixed hyperlipidemia
Beyond the preview
Go deeper on NCT07695597.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07695597.